O

    OrganiGram Holdings Inc (OGI)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $1.21
    -0.00 (-0.41%)

    Market Cap: $170.62M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    22%(8/36)
    Avg Surprise
    -334.22%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.46
    Range$0.46 - $0.46
    1 analysts
    Revenue Consensus
    $112M
    Range$109M - $114M
    5 analysts
    Period ending Dec 31, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $108M
    Range$100M - $115M
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-N/A---
    Sep 26EST
    		-$0.46---
    Jun 26
    Reported Aug 11
    		$-0.05$-0.01-400.00%Miss-400.0%
    Mar 26
    Reported May 12
    		$-0.01$-0.00-45.71%Miss-102.1%
    Dec 25
    Reported Feb 10
    		$-0.01$-0.01+0.00%Beat+90.9%
    Sep 25
    Reported Dec 16
    		$-0.28$-0.01-3900.00%Miss-176.7%
    Jun 25
    Reported Aug 13
    		$-0.01$-0.01+0.00%Beat-150.0%
    Mar 25
    Reported May 12
    		$0.24$-0.03+900.00%Beat+400.0%
    Dec 24
    Reported Feb 11
    		$-0.11$-0.02-450.00%Miss+21.4%
    Sep 24
    Reported Dec 18
    		$-0.10$-0.04-189.14%Miss+72.6%
    Jun 24
    Reported Aug 13
    		$0.02N/A+140.00%Beat+166.7%
    Mar 24
    Reported May 14
    		$-0.08$-0.07-14.29%Miss+20.0%
    Dec 23
    Reported Feb 13
    		$-0.14$-0.10-40.00%Miss-100.0%
    Sep 23
    Reported Dec 19
    		$-0.37$-0.02-1501.73%Miss-528.2%
    Jun 23
    Reported Jul 13
    		$-0.03$-0.06+50.00%Beat+0.0%
    Mar 23
    Reported Apr 11
    		$-0.10$-0.06-66.67%Miss+0.0%
    Dec 22
    Reported Jan 12
    		$-0.07$-0.06-16.67%Miss+50.0%
    Sep 22
    Reported Nov 28
    		$-0.06$-0.02-254.82%Miss+34.6%
    Jun 22
    Reported Jul 14
    		$-0.03$-0.06+50.00%Beat+85.0%
    Mar 22
    Reported Apr 12
    		$-0.10$-0.09-11.11%Miss+50.0%
    Dec 21
    Reported Jan 11
    		$-0.14$-0.09-55.56%Miss+46.2%
    Sep 21
    Reported Nov 23
    		$-0.09$-0.06-50.00%Miss+85.3%
    Jun 21
    Reported Jul 13
    		$-0.20$-0.12-66.67%Miss+68.8%
    Mar 21
    Reported Apr 13
    		$-0.20$-0.13-53.85%Miss-11.1%
    Dec 20
    Reported Jan 12
    		$-0.26$-0.12-116.67%Miss-333.3%
    Sep 20
    Reported Nov 30
    		$-0.61$-0.03-2347.01%Miss-338.7%
    Jun 20
    Reported Jul 21
    		$-0.64$-0.07-814.29%Miss-966.7%
    Mar 20
    Reported Apr 14
    		$-0.18$-0.03-500.00%Miss-1000.0%
    Dec 19
    Reported Jan 14
    		$-0.06$-0.08+25.00%Beat-500.0%
    Sep 19
    Reported Nov 26
    		$-0.14$-0.04-250.00%Miss-130.8%
    Jun 19
    Reported Jul 15
    		$-0.06$0.08-175.00%Miss+60.0%
    Mar 19
    Reported Apr 15
    		$0.02N/A-77.78%Miss+128.6%
    Dec 18
    Reported Jan 28
    		$-0.01N/A+66.67%Beat+67.9%
    Sep 18
    Reported Dec 13
    		$0.45N/AN/ABeat+749.6%
    Jun 18
    Reported Jul 30
    		$-0.15$-0.06-150.00%Miss-150.0%
    Mar 18
    Reported Apr 24
    		$-0.07$-0.03-133.33%Miss+58.8%
    Dec 17
    Reported Jan 29
    		$-0.03N/AN/ABeat-6.5%
    Sep 17
    Reported Dec 18
    		$-0.07$0.03-333.33%Miss-329.5%
    Jun 17
    Reported Jul 28
    		$-0.06$-0.01-500.00%Miss-
    Mar 17
    Reported Apr 28
    		$-0.17$-0.02-750.00%Miss-
    Dec 16
    Reported Jan 24
    		$-0.03N/AN/ABeat-
    Sep 16
    Reported Dec 13
    		$0.03N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-4.62EV/EBITDA13.95x
    Price/FCF-6.73xFCF Yield-14.86%
    Profitability
    Profit Margin28.00%Operating Margin5.04%
    ROE17.60%ROIC-0.60%
    Financial Health
    Debt/Equity0.01xInterest CoverageN/A
    Current Ratio2.61xQuick Ratio1.07x
    Trading Statistics
    Beta1.85Avg Volume1.74M
    52-Week High$2.2452-Week Low$0.85

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.23
    SMA 20$1.18
    SMA 50$1.04
    SMA 200$1.34
    EMA 10$1.22
    EMA 20$1.18
    EMA 50$1.12
    EMA 200$1.26

    MACD

    Line: 0.06Signal: 0.06Hist: -0.00

    ADX

    ADX: 34.4+DI: 23.7-DI: 16.4

    Aroon & PSAR

    Aroon Up52.0
    Aroon Down8.0
    PSAR$1.30

    Bollinger Bands

    Upper Band$1.40
    Lower Band$0.96
    %B Position3712%(Upper)
    Band Width0.57

    RSI (14-Day)

    Neutral
    58.9

    Momentum Oscillators

    Stoch %K52.1
    Stoch %D67.0
    Williams %R-64.7
    ROC (10d)-1.2%
    Momentum-0.01
    CCI (20d)22.3
    MFI (14d)50.5

    Volatility Measures

    ATR (14d)$0.06(4.7%)
    StdDev (20d)0.11
    Hist Vol72.4%(High)

    Volume Flow

    VWAP$1.20
    OBV7.8M
    AD Line2.9M
    CMF (20d)0.617

    Volume Metrics

    Avg Vol (20d)1.8M
    Vol Ratio0.1x(Low)
    VWMA (20d)$1.22

    Pivot Points

    R3$1.27
    R2$1.25
    R1$1.23
    Pivot Point$1.21
    S1$1.20
    S2$1.18
    S3$1.16

    Advanced Oscillators

    TSI30.09
    Ultimate Osc63.2
    KST278.75

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$105.78M$59.79M$63.49M$80.06M$70.79M$65.60M$42.73M$44.70M$41.06M$37.63M$36.45M$46.04M
    Cost of Revenue$64.36M$43.39M$40.22M$48.22M$44.65M$47.18M$28.92M$27.48M$27.05M$38.54M$29.75M$58.79M
    Gross Profit$41.42M$16.41M$23.32M$31.84M$26.15M$18.42M$13.81M$17.22M$14.01M$-908,000$6.70M$-12,746,000
    Operating Expenses$36.09M$26.20M$26.73M$30.65M$28.25M$26.00M$20.61M$16.93M$19.06M$23.47M$22.63M$26.61M
    R&D$2.21M$2.02M$2.08M$3.15M$2.76M$2.66M$2.37M$1.67M$2.46M$2.61M$4.47M$4.01M
    SG&A$21.76M$13.33M$13.42M$16.37M$14.42M$13.61M$11.38M$9.55M$10.54M$15.63M$12.75M$0
    Operating Income$5.33M$-9,793,000$-3,418,000$1.19M$-2,105,000$-7,583,000$-6,801,000$283,000$-5,048,000$-15,147,000$-15,929,000$-39,361,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$541,234$0$52,414$52,414$14.09M$124,376$573,292$5.69M$52,000$65,000$48,000$133,000
    Income Before Tax$103.95M$-921,000$19.95M$-41,725,000$-16,197,000$42.35M$-22,957,000$-5,403,000$2.94M$-27,105,000$-15,750,000$-35,270,000
    Income Tax Expense$-1,590,000$0$-3,761,000$-3,761,000$-9,903,000$-106,000$0$30,000$122,000$-30,000$111,000$-2,279,000
    Net Income$105.54M$-921,000$19.95M$-37,964,000$-6,294,000$42.46M$-22,957,000$-5,433,000$2.82M$-27,075,000$-15,750,000$-32,991,000
    EBITDA$16.13M$-4,760,000$1.56M$6.15M$2.68M$-2,744,000$-3,414,000$7.27M$5.91M$-12,017,000$-12,865,000$-29,700,000
    EBIT$5.33M$-9,793,000$-3,413,941$1.19M$-2,105,000$-7,583,000$-6,801,000$4.20M$2.87M$-15,147,000$-15,702,000$-35,122,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OGI

    News

    Organigram Global (NASDAQ: OGI): Why Is The latest sector session kept branded-product execution in focus in Focus Now?

    Organigram Global (NASDAQ: OGI) is under focus due to a recent sector session emphasizing branded-product execution, making brand demand and product mix central to its strategy. This development offers a fresh operating reference point for investors to assess the company's execution, business resilience, and future operating evidence without relying solely on price-based interpretations. The article delves into the importance of this update, the operating backdrop, business model, demand signals, execution, capital discipline, competitive positioning, and associated risks.

    Kalkine Media•8/24/26•
    Neutral

    Organigram integrates Sanity Group, appoints new executives By Investing.com

    Organigram Global Inc. announced the integration of Sanity Group GmbH and new executive appointments as part of its global expansion. The company amended the share purchase agreement for Sanity, replacing a performance-based earnout with a fixed earnout of €20 million cash and approximately €76 million in Organigram shares. Sanity contributed significantly to Organigram's recent net revenue, and the integrated network will span several countries including Canada, Germany, and Australia.

    Investing.com Nigeria•8/21/26•
    Bullish

    Sanity revenue jumps 34% as Organigram (NASDAQ: OGI) reshapes German deal

    Organigram Global Inc. is accelerating the integration of its German subsidiary, Sanity Group GmbH, moving to a unified global operating model. Sanity Group contributed CAD$40 million to Organigram's recent quarterly net revenue, representing over 35% of the total, and its quarterly revenue has increased by 34% to €25.5 million since December 31, 2025. Organigram has also amended the Sanity acquisition agreement, replacing the performance-based earnout with a fixed earnout set at 85% of the original maximum, payable in cash and Organigram shares by May 1, 2027.

    Stock Titan•8/21/26•
    Bullish

    Organigram integrates Sanity Group, appoints new executives

    Organigram Global Inc. has announced the integration of Sanity Group GmbH and new executive appointments as part of its global expansion. The company appointed Finn Age Hänsel as President, Rest of World & Chief Strategy Officer, and Adrian Frenzel as Global Chief Operating Officer, while amending the Sanity acquisition agreement to a fixed earnout of €20 million cash and approximately €76 million in Organigram shares. Sanity Group significantly contributed to Organigram's recent quarterly revenue, and the combined entity will expand its network across several countries.

    Investing.com•8/20/26•
    Bullish

    Organigram Global Stock Drops 3.43% as Investors Weigh Cannabis Growth, International Expansion and Profitability

    Organigram Global Inc. (TSX:OGI) experienced a 3.43% stock decline as investors assessed its competitive position in the Canadian cannabis market, international expansion prospects, and pathway to profitability. The company aims to achieve sustainable growth through product diversification, operational efficiency, and market share gains amidst intense industry competition and evolving consumer preferences. Key factors influencing investor sentiment include pricing pressures, regulatory environments, and the challenge of converting revenue growth into positive free cash flow.

    kalkine.ca•8/17/26•
    Somewhat-Bearish

    Frequently Asked Questions About OGI

    Does OGI pay dividends?
    OrganiGram Holdings Inc (OGI) does not currently pay a regular dividend.
    What is OGI's market cap?
    OrganiGram Holdings Inc (OGI) has a market capitalization of $170.62M with a current stock price of $1.21.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In